The Multiple Facets of Cigarette Addiction and What They Mean for Encouraging and Helping Smokers to Stop

REFERENCES

• RCP. Nicotine Addiction in Britain. Royal College of Physicians, London 2000
   Google Scholar
• Baron J. Thinking and Deciding. Cambridge University Press, Cambridge 2000
   Google Scholar
• Mook D G. Motivation: the Organization of Action. W. W. Norton, New Yotk 1996
   Google Scholar
• Baumeister R F, Heatherton T F, Tice D M. Losing Control: How and Why People Fail at Self-regulation. Academic Press, San Diego 1994
   Google Scholar
• West R. Theory of Addiction. Blackwells, Oxford 2006
   Google Scholar
• Russell M A, Feyerabend C. Cigarette smoking: a dependence on high-nicotine boli. Drug Metab Rev 1978; 8(1)29–57
   PubMed Web of Science ®Google Scholar
• Corrigall W A, Coen K M, Adamson K L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 1994; 653(1–2)278–284
   PubMed Web of Science ®Google Scholar
• Pons S, et al. Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci 2008; 28(47)12318–12327
   PubMed Web of Science ®Google Scholar
• Laviolette S R, et al. Dopamine signaling through D1-like versus D2-like receptors in the nucleus accumbens core versus shell differentially modulates nicotine reward sensitivity. J Neurosci 2008; 28(32)8025–8033
   PubMed Web of Science ®Google Scholar
• Ikemoto S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev 2007; 56(1)27–78
   PubMed Web of Science ®Google Scholar
• Balfour D J. The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens (corrected). Nicotine Tob Res 2004; 6(6)899–912
   PubMed Web of Science ®Google Scholar
• Ferguson S G, Shiffman S. The relevance and treatment of cue-induced cravings in tobacco dependence. J Subst Abuse Treat 2008
   PubMed Web of Science ®Google Scholar
• Dawkins L, et al. A double-blind placebo-controlled experimental study of nicotine: II—Effects on response inhibition and executive functioning. Psychopharmacology (Berl) 2007; 190(4)457–467
   PubMed Web of Science ®Google Scholar
• Balfour D J. The neuronal pathways mediating the behavioral and addictive properties of nicotine. Handb Exp Pharmacol 2009; 192: 209–233
   PubMedGoogle Scholar
• Caggiula A R, et al. The role of nicotine in smoking: a dual-reinforcement model. Nebr Symp Motiv 2009; 55: 91–109
   PubMed Web of Science ®Google Scholar
• Foulds J. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline. Int J Clin Pract 2006; 60(5)571–576
   PubMed Web of Science ®Google Scholar
• Burling A S, Burling T A. A comparison of self-report measures of nicotine dependence among male drug/alcohol-dependent cigarette smokers. Nicotine Tob Res 2003; 5(5)625–633
   PubMed Web of Science ®Google Scholar
• West R. Defining and assessing nicotine dependence in humans. Understanding Nicotine and Tobacco Addiction, G Bock, J Goode. Wiley, London 2006; 36–51
   Google Scholar
• Hughes J R. Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review. Nicotine Tob Res 2007; 9(3)329–339
   PubMed Web of Science ®Google Scholar
• Hughes J R. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 2007; 9(3)315–327
   PubMed Web of Science ®Google Scholar
• Piasecki T M. Relapse to smoking. Clin Psychol Rev 2006; 26(2)196–215
   PubMed Web of Science ®Google Scholar
• Dawkins L, et al. A double-blind placebo controlled experimental study of nicotine: I-effects on incentive motivation. Psychopharmacology (Berl) 2006; 189(3)355–367
   PubMed Web of Science ®Google Scholar
• McEwen A, West R, McRobbie H. Motives for smoking and their correlates in clients attending Stop Smoking treatment services. Nicotine Tob Res 2008; 10(5)843–850
   PubMed Web of Science ®Google Scholar
• Yong H H, Borland R. Functional beliefs about smoking and quitting activity among adult smokers in four countries: findings from the International Tobacco Control Four-Country Survey. Health Psychol 2008; 27(3 Suppl)S216–223
   PubMed Web of Science ®Google Scholar
• Zhou X, et al. Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav 2009; 34(4)365–373
   PubMed Web of Science ®Google Scholar
• Siahpush M, Spittal M, Singh G K. Smoking cessation and financial stress. J Public Health (Oxf) 2007; 29(4)338–342
   PubMed Web of Science ®Google Scholar
• O'Connell K A, Schwartz J E, Shiffman S. Do resisted temptations during smoking cessation deplete or augment self-control resources?. Psychol Addict Behav 2008; 22(4)486–495
   PubMed Web of Science ®Google Scholar
• West R, Sohal T. “Catastrophic” pathways to smoking cessation: findings from national survey. BMJ 2006; 332(7539)458–460
   PubMed Web of Science ®Google Scholar
• Hughes J R, et al. Intentions to quit smoking change over short periods of time. Addict Behav 2005; 30(4)653–662
   PubMed Web of Science ®Google Scholar
• Pisinger C, et al. It is possible to help smokers in early motivational stages to quit; The Inter99 study. Prev Med 2005; 40(3)278–284
   PubMed Web of Science ®Google Scholar
• West R. Nicotine is addictive: the issue of free choice. The Effects of Nicotine on Biological Systems II, P. Clarke, et al. Birkhauser, Berlin 1995
   Google Scholar
• Hughes J R, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004; 99(1)29–38
   PubMed Web of Science ®Google Scholar
• Shiffman S, Ferguson S G, Gwaltney C J. Immediate hedonic response to smoking lapses: relationship to smoking relapse, and effects of nicotine replacement therapy. Psychopharmacology (Berl) 2006; 184(3–4)608–618
   PubMed Web of Science ®Google Scholar
• Shiffman S, Ferguson S G. Nicotine patch therapy prior to quitting smoking: a meta-analysis. Addiction 2008; 103(4)557–563
   PubMed Web of Science ®Google Scholar
• West R, et al. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacology (Berl) 2008; 197(3)371–377
   PubMed Web of Science ®Google Scholar
• Cahill K, Stead L F, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2008, (3):CD006103
   Web of Science ®Google Scholar
• Stead L F, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008, (1):CD000146
   Web of Science ®Google Scholar
• Hughes J R, Stead L F, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007, (1): p. CD000031
   Google Scholar
• Shiffman S. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial. Clin Ther 2008; 30(8)1461–475
   PubMed Web of Science ®Google Scholar
• Gwaltney C J, et al. Dynamic self-efficacy and outcome expectancies: prediction of smoking lapse and relapse. J Abnorm Psychol 2005; 114(4)661–675
   PubMed Web of Science ®Google Scholar
• West R J, Hajek P, Belcher M. Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol Med 1989; 19(4)981–985
   PubMed Web of Science ®Google Scholar
• Shiffman S, et al. A day at a time: predicting smoking lapse from daily urge. J Abnorm Psychol 1997; 106(1)104–116
   PubMed Web of Science ®Google Scholar